Table 1.
Total | No. (%)
Columbia |
Cornell | p-value* | |
---|---|---|---|---|
Number of patients | 354 (100%) | 197 (56%) | 157 (44%) | |
Mean age, years (S.D.) | 63.8 (12.0) | 66.2 (11.7) | 60.8 (11.8) | <0.0001 |
Male sex | 270 (76%) | 140 (71%) | 130 (83%) | 0.01 |
Smokers (ever) | <0.001 | |||
Never | 106 (30%) | 33 (17%) | 73 (46%) | |
Ever | 183 (52%) | 99 (50%) | 84 (53%) | |
Unknown | 65 (18%) | 65 (33%) | 0 (0%) | |
Race/ethnicity | <0.001 | |||
White | 260 (74%) | 117 (59%) | 143 (92%) | |
Black | 33 (9%) | 25 (13%) | 8 (5%) | |
Hispanic | 33 (9%) | 33 (17%) | 0 (0%) | |
Other | 27 (8%) | 22 (11%) | 5 (3%) | |
Tumor histology | 0.19 | |||
Adenocarcinoma | 201 (57%) | 104 (53%) | 97 (62%) | |
Squamous cell | 131 (37%) | 81 (41%) | 50 (32%) | |
Other | 22 (7%) | 12 (6%) | 10 (6%) | |
Tumor subsite | 0.05 | |||
GE junction | 65 (19%) | 41 (21%) | 24 (16%) | |
Lower esophagus | 182 (52%) | 94 (48%) | 88 (58%) | |
Mid-esophagus | 71 (20%) | 38 (19%) | 33 (22%) | |
Upper esophagus | 32 (9%) | 24 (12%) | 8 (5%) | |
Site of metastasis† | ||||
Lung | 53 (15%) | 28 (14%) | 25 (16%) | 0.66 |
Liver | 56 (16%) | 20 (10%) | 36 (23%) | <0.001 |
Other | 86 (24%) | 32 (16%) | 54 (34%) | <0.001 |
Stage at diagnosis | ||||
1-3 | 330 (93%) | 173 (88%) | 157 (100%) | <0.001 |
4 | 24 (7%) | 24 (12%) | 0 (0%) |
For comparison between Columbia and Cornell study sites.
Some subjects had multiple sites of metastasis.